Fentanyl — Class III drug recall D-0147-2021
Terminated recall by SCA Pharmaceuticals, reported 2020-12-23, distributed in LA, MO. Subpotency: Out-of-specification stability test result for low potency was obtained.
| Recall number | D-0147-2021 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | SCA Pharmaceuticals, Windsor, CT, United States |
| Recall initiated | 2020-11-20 |
| Classified | 2020-12-14 |
| Reported by FDA | 2020-12-23 |
| Terminated | 2021-06-24 |
| Distributed | LA, MO |
| Quantity | 4,843 syringes |
| Reason classes | potency, specification failure |
| Lot numbers | 1220021578, 1220021732, 1220022385, 1220022582 |
| Expiration dates | 2020-12-02, 2020-12-09, 2020-12-29, 2021-01-06 |
Product
Fentanyl, 250 mcg/ 5mL, Injection for IV or IM use, Rx only, SCA Pharmaceuticals, 8821 Knoedl Ct., Little Rock, AR 72205
Reason for recall
Subpotency: Out-of-specification stability test result for low potency was obtained.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0147-2021. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.